Why Osteoporosis Isn't Just a Senior Problem Anymore
Osteoporosis is called the 'silent thief' because it quietly eats away at bone strength over time—until a fracture reveals the damage. Other risk factors like lifestyle and medical conditions also contribute to osteoporosis. This affects people across the lifespan from children with genetic bone disorders to adults with hormonal shifts and chronic inflammation.
Despite being so common, osteoporosis is often misunderstood, undertreated or ignored. But new science is changing that, giving us new insights into how bones weaken, how to catch it early and how to protect skeletal health for life.
At its core Osteoporosis is a disease of bone imbalance. Normally our bones are constantly renewing themselves—old tissue gets broken down and new tissue replaces it. But when this balance tips either by losing too much bone or making too little bones become porous, brittle and prone to break. As bone loss occurs individuals may lose bone mass and increase the risk of fractures.
According to Aging Clinical and Experimental Research (2021) this imbalance can come from a variety of factors including hormonal changes (menopause), aging and even immune dysfunction [1]. These changes affect how cells within the bone operate and tip the scale towards bone loss. Imbalances in certain hormones can also significantly impact bone health.
Children aren't immune either. Disorders like osteogenesis imperfecta or chronic malnutrition can cause pediatric osteoporosis. As stated in Seminars in Musculoskeletal Radiology (2021) when bone growth is disrupted in early life—during rapid growth spurts or due to genetic factors—the result is lifelong fragility [2].
Family history is another risk factor as individuals with a family history of osteoporosis are more likely to experience bone loss. Osteoporosis is a medical condition that requires a licensed physician for proper diagnosis and treatment. Routine screenings as recommended by the U.S. Preventive Services Task Force are essential for osteoporosis diagnosed early. Almost everyone is at risk of developing osteoporosis due to aging and lifestyle choices.
Here's where things get even more interesting: bone health isn't just about calcium and exercise. The immune system and gut microbiome are also involved. A 2020 EXCLI Journal review states that chronic inflammation and microbial imbalances can weaken bones—linking osteoporosis to broader systemic issues like autoimmune diseases and gut disorders [3].
Chronic inflammation plays a big role in many osteoporosis cases. Conditions like rheumatoid arthritis accelerate bone loss not just because of the disease itself but because of the inflammatory chemicals involved. These substances called cytokines disrupt the delicate balance of bone remodeling. Nature Reviews Drug Discovery (2012) says pro-inflammatory cytokines can increase bone destruction and shut down new bone formation [8].
Another often overlooked factor is bone quality. We focus on bone mineral density (BMD) but that only tells part of the story. A person can have normal BMD and still fracture due to poor bone microarchitecture. In 2021 Instructional Course Lectures stated that bone strength also depends on its internal structure—like how well the collagen and mineral components are arranged [4].
Think of it like two buildings made of the same materials but one will collapse faster if the internal framework is weak. Bones are living tissue undergoing continuous remodeling where old bone is broken down and replaced with new bone.
The gold standard for diagnosing osteoporosis is the DEXA (dual-energy X-ray absorptiometry) scan which measures bone mineral density. A bone density test is essential for identifying the disease early. But diagnosis goes beyond numbers. Clinicians look at a person's risk factors for osteoporosis: age, gender, history of fractures, medications like steroids and chronic illnesses.
According to Lancet (2019) secondary fracture prevention programs such as Fracture Liaison Services (FLS) are proving to be essential tools in identifying patients who may have osteoporosis but were never formally diagnosed—especially after their first fracture [10].
These services help close the gap between injury and intervention so patients get the care they need before another break occurs. Healthcare providers diagnose osteoporosis during routine screenings following guidelines from the U.S. Preventive Services Task Force.
Osteoporosis treatment isn't just about pills—it's a lifelong approach to treating osteoporosis. Preventive measures like being active, eating a diet rich in calcium and vitamin D, not smoking and being at a healthy weight can go a long way.
Weight-bearing exercises like walking, jogging and dancing are essential for building and maintaining strong bones. Taking a calcium supplement can help you meet your daily recommended intake especially if your dietary calcium is inadequate.
But for those already affected, medications play a big role. Endocrinology and Metabolism Clinics (2015) stressed the importance of patient education saying that understanding the condition improves long-term treatment outcome [5]. Here are the common treatment options:
To prevent osteoporosis you need to adopt a healthy lifestyle that includes a balanced diet and regular physical activity.
P&T Journal (2018) noted that while these treatments are effective doctors must also consider cost, side effects and the patient's ability to adhere to the regimen when choosing a therapy plan [9]. Preventing fractures involves maintaining bone health through adequate calcium and vitamin D intake, prescribed medications and avoiding falls.
Weight-bearing exercise is particularly beneficial in preventing bone loss and reducing the risk of fractures as we age. Treating osteoporosis effectively requires a balanced approach that includes medication, diet and exercise.
Children with bone disorders need a more tailored approach. Their bones are still growing so doctors must be cautious with medications that might affect that process. A 2023 Current Osteoporosis Reports article emphasized the need for nuanced care strategies in kids with developmental delays or skeletal disorders [7].
The future of osteoporosis care is moving beyond one-size-fits-all approaches. As the 2023 Endocrinology and Metabolism Clinics review said, age, genetics, environment and lifestyle all play a role in determining bone health risk and treatment plan [6].
Achieving peak bone mass by 30 is key to reducing the risk of osteoporosis later in life. Maintaining bone mass over time is also crucial to reducing osteoporosis-related fractures.
That means looking at bone health from childhood to old age. Early-life interventions especially for children with chronic illnesses can build more bone for the future. In older adults, early screening and multidisciplinary care including primary care, endocrinology and geriatrics can prevent devastating fractures that often lead to disability or loss of independence.
Strategies to keep bones strong are a balanced diet rich in calcium and vitamin D and regular physical activity. Keeping bones healthy is weight-bearing exercise and preventing falls.
Osteoporosis isn't just a disease of aging—it's a lifelong concern that requires early awareness, proactive prevention and tailored treatment especially for those at high risk and increased risk. By understanding the complex interplay of inflammation, bone quality and individual risk factors we're moving towards more effective care for every stage of life. Osteoporosis risk is influenced by many medical conditions and lifestyle choices so preventive measures are key. The science is clear: strong bones start with strong strategies and the earlier we act the better the outcome.
[1] Barnsley, J., Buckland, G., Chan, P. E., Ong, A., Ramos, A. S., Baxter, M., Laskou, F., Dennison, E. M., Cooper, C., & Patel, H. P. (2021). Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging clinical and experimental research, 33(4), 759–773. https://doi.org/10.1007/s40520-021-01817-y
[2] Testini, V., Eusebi, L., Tupputi, U., Carpagnano, F. A., Bartelli, F., & Guglielmi, G. (2021). Metabolic Bone Diseases in the Pediatric Population. Seminars in musculoskeletal radiology, 25(1), 94–104. https://doi.org/10.1055/s-0040-1722566
[3] Föger-Samwald, U., Dovjak, P., Azizi-Semrad, U., Kerschan-Schindl, K., & Pietschmann, P. (2020). Osteoporosis: Pathophysiology and therapeutic options. EXCLI journal, 19, 1017–1037. https://doi.org/10.17179/excli2020-2591
[4] Dimar, J. R., Lane, J. M., Lehman, R. A., Jr, & Anderson, P. A. (2021). The Basics of Bone Physiology, Healing, and Osteoporosis. Instructional course lectures, 70, 527–536. https://pubmed.ncbi.nlm.nih.gov/33438933/
[5] Lupsa, B. C., & Insogna, K. (2015). Bone Health and Osteoporosis. Endocrinology and metabolism clinics of North America, 44(3), 517–530. https://doi.org/10.1016/j.ecl.2015.05.002
[6] Khandelwal, S., & Lane, N. E. (2023). Osteoporosis: Review of Etiology, Mechanisms, and Approach to Management in the Aging Population. Endocrinology and metabolism clinics of North America, 52(2), 259–275. https://doi.org/10.1016/j.ecl.2022.10.009
[7] Raimann, A., Misof, B. M., Fratzl, P., & Fratzl-Zelman, N. (2023). Bone Material Properties in Bone Diseases Affecting Children. Current osteoporosis reports, 21(6), 787–805. https://doi.org/10.1007/s11914-023-00822-6
[8] Redlich, K., & Smolen, J. S. (2012). Inflammatory bone loss: pathogenesis and therapeutic intervention. Nature reviews. Drug discovery, 11(3), 234–250. https://doi.org/10.1038/nrd3669
[9] Tu, K. N., Lie, J. D., Wan, C. K. V., Cameron, M., Austel, A. G., Nguyen, J. K., Van, K., & Hyun, D. (2018). Osteoporosis: A Review of Treatment Options. P & T : a peer-reviewed journal for formulary management, 43(2), 92–104. https://pubmed.ncbi.nlm.nih.gov/29386866/
[10] Compston, J. E., McClung, M. R., & Leslie, W. D. (2019). Osteoporosis. Lancet (London, England), 393(10169), 364–376. https://doi.org/10.1016/S0140-6736(18)32112-3
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
2 days ago
- UPI
Supportive doctors help LGBTQ patients stay healthier
Marchers carry a pride banner in the WorldPride 2025 Parade in Washington on Saturday. A study shows supportive care boosts the health of the LGBTQ community and cuts costs. File Photo by Leigh Vogel/UPI | License Photo June 10 (UPI) -- When LGBTQ+ patients are unsure if they can be open about their identity and related health needs, it becomes more difficult for them to access high-quality health care. In our recently published research, my colleagues and I found that how LGBTQ+ people are treated at the doctor's office has a measurable effect on whether they stay up to date with lifesaving preventive care like flu shots, colorectal cancer screenings and HIV testing. Results of affirming care We examined how LGBTQ+ adults rated their health care provider across three areas: LGBTQ+ cultural competency, such as if providers used inclusive language on forms and in person; LGBTQ+ clinical competency, such as their doctor's knowledge on all aspects of their health; and experiences of discrimination, such as being told to seek care elsewhere. After analyzing survey data on the experiences of more than 950 LGBTQ+ adults from across the U.S., we saw that three clear patterns emerged. First, 34% of participants reported having positive health care experiences - meaning their providers were culturally and clinically competent about LGBTQ+ health needs, and did not discriminate against them. These patients were more likely to be up to date on at least one preventive service recommended by the U.S. Preventive Services Task Force, compared to those receiving neutral or discriminatory care. Second, 60% of participants reported having neutral experiences, when their providers were clinically competent about LGBTQ+ health needs and didn't discriminate against them, but were not culturally competent. These patients were 43% less likely to get an HIV test compared to patients reporting affirming care. Third, 6% of participants reported experiencing discrimination, when their providers were neither culturally nor clinically competent on LGBTQ+ health. These patients were 24% less likely to get a colorectal cancer screening compared to patients reporting affirming care. Most LGBTQ+ adults in our study reported neutral or even discriminatory care, which leads to avoidable health risks and higher costs for the health system. This provides additional evidence that being supportive of LGBTQ+ patients has measurable improvements for health outcomes. Why preventive care matters Preventive care saves lives and saves money. When diseases like colorectal cancer or HIV are caught early, treatments are often simpler, more effective and less expensive. When LGBTQ+ patients are made to feel unwelcome or unsafe, we found that they are less likely to get routine preventive care, ultimately driving up long-term costs across the health system. States like North Carolina and Georgia that have more health systems participating in the Human Rights Campaign's Healthcare Equality Index, which evaluates policies and practices around LGBTQ+ care, had higher rates of LGBTQ+ patients reporting positive care experiences compared to states with few participating health systems, such as Tennessee and Alabama. Other researchers have found that health systems participating in the Healthcare Equality Index have lower rates of nurse burnout and better quality of care, along with higher patient satisfaction among all patients. Public health in crisis This study was originally funded by the National Institute on Aging, but it was among the first LGBTQ+-focused projects terminated by the Trump administration in its efforts to eliminate "gender ideology." Our team has continued the work independently to ensure that the over 1,250 participants who already shared their experiences and data would not have this information sit idly. Our findings reinforce what many LGBTQ+ patients already know - nonjudgmental and competent care is not a luxury, but a public health necessity. University of Illinois Chicago. This article is republished from The Conversation under a Creative Commons license. Read the original article. The views and opinions expressed in this commentary are solely those of the author.
Yahoo
2 days ago
- Yahoo
LGBTQ+ patients stay up-to-date on preventive care when their doctors are supportive, saving money and lives throughout society
When LGBTQ+ patients are unsure if they can be open about their identity and related health needs, it becomes more difficult for them to access high-quality health care. In our recently published research, my colleagues and I found that how LGBTQ+ people are treated at the doctor's office has a measurable effect on whether they stay up to date with lifesaving preventive care like flu shots, colorectal cancer screenings and HIV testing. We examined how LGBTQ+ adults rated their health care provider across three areas: LGBTQ+ cultural competency, such as if providers used inclusive language on forms and in person; LGBTQ+ clinical competency, such as their doctor's knowledge on all aspects of their health; and experiences of discrimination, such as being told to seek care elsewhere. After analyzing survey data on the experiences of more than 950 LGBTQ+ adults from across the U.S., we saw that three clear patterns emerged. First, 34% of participants reported having positive health care experiences – meaning their providers were culturally and clinically competent about LGBTQ+ health needs, and did not discriminate against them. These patients were more likely to be up to date on at least one preventive service recommended by the U.S. Preventive Services Task Force, compared to those receiving neutral or discriminatory care. Second, 60% of participants reported having neutral experiences, when their providers were clinically competent about LGBTQ+ health needs and didn't discriminate against them, but were not culturally competent. These patients were 43% less likely to get an HIV test compared to patients reporting affirming care. Third, 6% of participants reported experiencing discrimination, when their providers were neither culturally nor clinically competent on LGBTQ+ health. These patients were 24% less likely to get a colorectal cancer screening compared to patients reporting affirming care. Most LGBTQ+ adults in our study reported neutral or even discriminatory care, which leads to avoidable health risks and higher costs for the health system. This provides additional evidence that being supportive of LGBTQ+ patients has measurable improvements for health outcomes. Preventive care saves lives and saves money. When diseases like colorectal cancer or HIV are caught early, treatments are often simpler, more effective and less expensive. When LGBTQ+ patients are made to feel unwelcome or unsafe, we found that they are less likely to get routine preventive care, ultimately driving up long-term costs across the health system. States like North Carolina and Georgia that have more health systems participating in the Human Rights Campaign's Healthcare Equality Index, which evaluates policies and practices around LGBTQ+ care, had higher rates of LGBTQ+ patients reporting positive care experiences compared to states with few participating health systems, such as Tennessee and Alabama. Other researchers have found that health systems participating in the Healthcare Equality Index have lower rates of nurse burnout and better quality of care, along with higher patient satisfaction among all patients. This study was originally funded by the National Institute on Aging, but it was among the first LGBTQ+-focused projects terminated by the Trump administration in its efforts to eliminate 'gender ideology.' Our team has continued the work independently to ensure that the over 1,250 participants who already shared their experiences and data would not have this information sit idly. Our findings reinforce what many LGBTQ+ patients already know – nonjudgmental and competent care is not a luxury, but a public health necessity. This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Nathaniel M. Tran, University of Illinois Chicago Read more: Anti-LGBTQ+ policies harm the health of not only LGBTQ+ people, but all Americans Heteronormativity in health care is harmful for LGBTQ+ patients – and a source of tension for queer and trans doctors Our trans health study was terminated by the government – the effects of abrupt NIH grant cuts ripple across science and society Nathaniel M. Tran received funding from the National Institute on Aging and Vanderbilt University.
Yahoo
22-05-2025
- Yahoo
Trump suggested Biden hid cancer diagnosis. Here's what we know about the timeline
In May 2025, four months after his term ended, the office of former U.S. President Joe Biden announced he was diagnosed with Stage 4 metastatic prostate cancer. Skeptics, including President Donald Trump, questioned the timing of the announcement, suggesting it was improbable the cancer was not diagnosed earlier, while Biden was in office, but hidden from the public. A Biden spokesperson claimed he was most recently tested for prostate cancer in 2014, when he was 71 or 72 and still vice president. The U.S. Preventive Services Task Force suggests doctors not test men over 70, given the risks associated with cancer treatment and the likelihood an individual of that age will die from other competing factors before prostate cancer ends his life. Similarly, the American Cancer Society suggests doctors not test men with a life expectancy of less than 10 years for prostate cancer. Given the aggressive nature of Biden's cancer (9 out of 10 on the Gleason scale), it's not implausible that malignant cells developed more recently and metastasized at a faster rate, though it's impossible to assess the details of Biden's case without publicly available test records. Given the dearth of actual evidence to date, it's also impossible to ascertain whether Biden's prostate cancer was diagnosed earlier than was claimed and was kept from the public. Four months after former U.S. President Joe Biden left the White House in January 2025, his office announced he had received a diagnosis of aggressive prostate cancer. Immediately, social media users (archived, archived, archived) and public detractors, including President Donald Trump, suggested Biden received a diagnosis while in office and hid it from the American public. Dozens of Snopes readers also inquired as to the timing of Biden's diagnosis. (X user @quay_dr) Biden's disclosure of his diagnosis came around the time a book by journalists Jake Tapper and Alex Thompson published, titled, "Original Sin: President Biden's Decline, Its Cover-Up, and His Disastrous Choice to Run Again." In it, the authors claimed Biden's office attempted to hide the extent of Biden's "serious decline." In a news conference on May 19, Trump further suggested Biden may have hidden test results from the public. "I think it's very sad, actually. I'm surprised that the public wasn't notified a long time ago because to get to Stage 9 [sic], that's a long time," Trump said. At minute 3:00, he added, "Somebody is not telling the facts." (For the record, there is no such thing as "Stage 9 cancer"; Biden received a Stage 4 diagnosis.) Biden's office rebutted these allegations on May 20. Chris Meagher, a Biden spokesperson, said in a statement that Biden's last prostate-specific antigen (PSA) test took place in 2014, when Biden was 71 or 72 years old, meaning Biden did not receive a diagnosis while serving as president. We reached out to Biden's office seeking confirmation and will update this story if we receive a response. Certain questions persist. For example, given the importance of the president's health, why didn't Biden's medical team regularly screen him for one of the most common types of cancer among older men? Why wasn't it caught earlier? Below, we break down what we know about the timing of Biden's diagnosis, how quickly Biden's cancer could have spread, and whether law requires U.S. presidents to disclose information about their health to the American public. The cancer had already spread to the former president's bones at the time his illness was announced, meaning the disease was aggressive and likely incurable at that point. Biden's detractors claimed he should have received regular screenings for prostate cancer, which is the second most common form of cancer in American men next to skin cancer (which Biden has also received treatment for in the past). The truth is a little more complicated. According to the U.S. Centers for Disease Control (CDC), the most common risk factor for prostate cancer is age. "The older a man is, the greater the chance of getting prostate cancer," its website reads. The American Cancer Society posits that "most prostate cancers are found in men over the age of 65." Biden received testing after he reported "increasing urinary symptoms." If he hadn't shown physical symptoms, it's unlikely he would have undergone PSA testing or caught the cancer. So then why would the U.S. president — who turned 82 in November 2024 and was the oldest serving U.S. president in history — have skipped this test for more than a decade as he got older? There are a number of factors that can contribute to older individuals not undergoing PSA tests. Biopsies following a positive PSA test can be harmful and lead to bleeding, infection, etc., and only 25% of patients who have biopsies following elevated PSA levels actually have prostate cancer. Treatment (such as radiation) for a positive biopsy result is also significantly taxing on the body, especially for an older individual, and can lead to a number of harms, including a 50% risk of long-term sexual erectile dysfunction and up to a one in six chance of long-term irritable bowel symptoms, according to the U.S. Preventive Services Task Force (USPSTF, or Task Force). The Task Force is an independent, volunteer panel of national experts, according to its website. Additionally, the government-backed Task Force — which The New York Times, CDC and others cited — recommends against PSA-based screening for prostate cancer in "men 70 years and older." This is because, while the risk of prostate cancer peaks above age 75, according to the CDC, there is a competing risk of other causes of death and life expectancy is, on the whole, not higher than the typical time it would take for the cancer to physically affect an individual. The reasoning the Task Force gave in 2018 is as follows: PSA-based screening for prostate cancer leads to the diagnosis of prostate cancer in some men whose cancer would never have become symptomatic during their lifetime. Treatment of these men results in harms and provides them with no benefit. This is known as overdiagnosis, and follow-up of large randomized trials suggests that 20% to 50% of men diagnosed with prostate cancer through screening may be overdiagnosed.3 Overdiagnosis rates would be expected to increase with age and to be highest in men 70 years and older because older men have high risk of death from competing causes. Not all doctors agree with this suggestion, especially as the life expectancy ceiling continues to rise. The American Cancer Society suggests that doctors not test individuals with a life expectancy of less than 10 years for prostate cancer. It does not specify an exact age. "[Biden] could be receiving the best medical care that we have to offer as a nation and not be screened for prostate cancer," Dr. Michael Morris, a Memorial Sloan Kettering oncologist who specializes in treating prostate cancer, told USA Today in a story on May 20, 2025. "Excellent care means not under-testing. It also means not over-testing." In 2019, Biden received a diagnosis of benign prostatic hyperplasia (BPH), a nonthreatening overgrowth of prostate cells common in older men. According to the Canadian Cancer Society, BPH does not increase the risk of prostate cancer. Despite the risks associated with biopsies and treatment, many individuals do choose to undergo testing anyway. A number of factors can influence this decision, including genetic predisposition, resources available or out of an abundance of caution. Former presidents have published their PSA results, given that their health is a matter of national interest. Trump, who is 78, has received regular PSA screenings. His last report, published in April 2025, shows his PSA level was normal. Former President Barack Obama also published his PSA test results while in office. The X post displayed above — which had accumulated more than 5.6 million views as of this writing — claimed that "for even with the most aggressive form, it is a 5-7 year journey without treatment before it becomes metastatic." (Metastatic means that the cancer has spread from the primary site to other places in the body.) Biden scored a level 9 out of 10 on the Gleason scale, which means that the prostate cancer cells look very different from healthy cells, according to the Cleveland Clinic. The higher the score, the more aggressive and lethal the cancer. Prostate cancer cells develop at different rates. While it is true that prostate cancer can develop very slowly — so slowly that an individual is more likely to die from another cause before the cancer cells metastasize — that is not always the case. "Most high-grade prostate cancers are also born that way and will behave aggressively," Dr. Marc B. Garnick, a prostate cancer specialist at Beth Israel Deaconess Medical Center said in a story for Harvard Health Publishing. The X post claimed that "it would be malpractice for this patient to show up and be first diagnosed with metastatic disease in May 2025." However, based on the medical considerations enumerated above, such a late diagnosis does not necessarily indicate malpractice. U.S. law does not require presidents to disclose details regarding their health to the public, though it is not uncommon to do so. Multiple U.S. presidents throughout history have kept details of their personal health from the public, including former President Woodrow Wilson, who hid the results of a stroke from the public from 1919 through the end of his presidency in 1921, and former President John F. Kennedy, who hid multiple diseases, including Addison's disease, from the public to maintain his youthful image. Alleged signs of Biden's mental and physical decline were a constant source of criticism during his administration, particularly after he announced his run for reelection. Biden refused to take a cognitive test throughout his presidency, and after a debate performance in which his voice trailed off mid-response more than once, then-Vice President Harris took over the campaign. In the lead-up to the 2024 presidential election, Harris made her medical information public in an effort to draw attention to Trump's refusal to do so, according to Reuters. A Biden spokesperson claimed the former president's most recent test for prostate cancer took place in 2014, when he was 71 or 72. Although the risk of prostate cancer increases with age, the American Cancer Society suggests doctors not test men with a life expectancy of less than 10 years for prostate cancer, given the harms associated with treatment and the likelihood that an individual over a certain age is prone to die from other competing factors before prostate cancer poses a serious risk to their life. The U.S. Preventive Services Task Force more specifically suggests that men over the age of 70 skip testing altogether. Given the aggressiveness of Biden's cancer, it's possible the cancerous cells developed more recently and metastasized at a faster rate, but it's impossible to know the details without publicly available test records. U.S. law doesn't require presidents to disclose details regarding their health to the public, though it is not uncommon to do so. Biden's health in particular, as the oldest serving president in U.S. history, drew extra scrutiny. Alltucker, Ken. 'Biden Has an Aggressive Form of Prostate Cancer. Should It Have Been Caught Earlier?' USA TODAY, Accessed 22 May 2025. American Cancer Society Recommendations for Prostate Cancer Early Detection. Accessed 22 May 2025. 'Benign Prostatic Hyperplasia (BPH)'. Canadian Cancer Society, Feb. 2021, 'Biden's Disastrous Debate Performance Offers Lessons for Harris and Warnings for Trump'. AP News, 7 Sept. 2024, Cancer Facts for Men | Common Cancers in Men. Accessed 22 May 2025. CDC. 'Prostate Cancer Risk Factors'. Prostate Cancer, 27 Aug. 2024, Dai, Xiaoyu, et al. 'Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer'. Medicine, vol. 95, no. 18, May 2016, p. e3493. PubMed Central, Desk, NPR Washington. 'Biden's Team Refutes Trump's Suggestion That Biden Hid His Cancer Diagnosis'. NPR, 20 May 2025. NPR, Desk, Washington. 'Biden Had Skin Cancer Removed from Chest during His Physical, White House Says'. NPR, 3 Mar. 2023. NPR, 'Fact Check: Misinformation after Biden's Cancer Diagnosis – DW – 05/20/2025'. Accessed 22 May 2025. Grubb, Robert L., et al. 'Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: Update on Findings from the Initial Four Rounds of Screening in a Randomized Trial'. BJU International, vol. 102, no. 11, Dec. 2008, pp. 1524–30. PubMed, Healthy Men Over 75: Don't Stop PSA Screening. Accessed 22 May 2025. 2 Feb. 2011, Mason, Jeff, and Jeff Mason. 'Harris Releases Medical Report, Drawing Contrast with Trump'. Reuters, 12 Oct. 2024. Mistry, Sandeep, et al. 'Who's Too Old to Screen? Prostate Cancer in Elderly Men'. Canadian Urological Association Journal, vol. 3, no. 3, June 2009, pp. 205–10. PubMed Central, Pager, Tyler. 'Biden Did Not Get Prostate Cancer Diagnosis Before Last Week, Spokesman Says'. The New York Times, 20 Mar. 2025, Pendick, Daniel. 'Prostate Cancer Lives as It Is Born: Slow-Growing and Benign or Fast-Growing and Dangerous'. Harvard Health, 14 Aug. 2013, Rackley, Fay. 'What Does Biden's Cancer Diagnosis Mean?' Boston University, 21 May 2025, 'Read the Report on President Trump's Annual Physical Exam'. The New York Times, 13 Apr. 2025. Recommendation: Prostate Cancer: Screening | United States Preventive Services Taskforce. Accessed 22 May 2025. Resources for News Media - NCI. 23 Apr. 2015, Tapper, Jake, and Alex Thompson. Original Sin: President Biden's Decline, Its Cover-Up, and His Disastrous Choice to Run Again. Random House, 2025. Treisman, Rachel. 'How Treatable Is Prostate Cancer? A Doctor Reacts to Biden's Diagnosis'. NPR, 19 May 2025. NPR, 'Trump Allies Shift from Well-Wishes to Suggesting Biden Hid His Cancer Diagnosis'. NBC News, 19 May 2025, 'Until What Age Should You Be Screened for Prostate Cancer?' Keck Medicine of USC, Accessed 22 May 2025. What Is Prostate Cancer? | Types of Prostate Cancer. Accessed 22 May 2025. 'What's a Gleason Score?' Cleveland Clinic, Accessed 22 May 2025. - YouTube. Accessed 22 May 2025.
